4BB (4BB) News
Follow 4BB (4BB) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 4 public stories across 2 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
4basebio conditionally raises about £15 million in equity
4basebio conditionally raised about £15.0 million through a placing and subscriptions. A further retail offer of up to £0.5 million is proposed, and completion is subject to shareholder approval. Debt will be reduced via
EQUITY | Oct 15, 2026, 02:17 PM UTC
L
4basebio PLC (4BB) To Supply opDNA for Client’s Phase I; TriLink Named CDMO
4basebio will supply clinical—grade opDNA starting material for a multi—national pharma client’s Phase I cell therapy program, with TriLink BioTechnologies selected as CDMO to manufacture the mRNA drug substance using Cl
NEWS | Sep 28, 2026, 11:09 AM UTC
L
4basebio and TriLink BioTechnologies Partner to Advance Leading Pharmaceutical Company’s Phase I Cell Therapy Program
CAMBRIDGE, UK — 28 September, 2026 — 4basebio PLC AIM:4BB, a specialist in enzymatically-produced DNA for new genetic medicines, announces they will supply clinical-grade opDNA® starting material for a multi-national pha
NEWS | Sep 28, 2026, 11:08 AM UTC
L
dpa-AFX Overview: Analyst recommendations on U.K. stocks
FRANKFURT (dpa-AFX) - The following investment banks issued recommendationson U.K. stocks this morning as follows:Analyst recommendations in the dpa-AFX International ProFeed on 28.09.2026 -11.00 am- BARCLAYS RAISES CROD
NEWS | Sep 28, 2026, 09:16 AM UTC